Iran Ceasefire Extended, Markets Pull Back: A Market Research Analysis

Good Tuesday evening. If you read yesterday's post on Europe Retreats, Asia's Indices Advance: A Split Market Research Analysis, you'll remember we were tracking a divergence between European weakness and Asian resilience. Today, that divergence largely collapsed. Almost everything sold off together, with a few notable exceptions in East Asia.

Here is the core thesis for today: the ceasefire extension reduced immediate war risk but not inflation risk, so global markets de-risked broadly. Let me walk through what happened, why, and what the research subjects look like on the other side of it.

The Big Driver: Iran Ceasefire Extended, But Uncertainty Didn't Leave

The headline that shaped today's session was President Trump extending the ceasefire with Iran. Pakistan, which has been mediating, requested the extension just hours before hostilities were set to resume. On the surface, that sounds like good news, and it is, in the sense that bombs are not currently falling. But markets didn't rally on it. They pulled back.

Why? Because a ceasefire extension is not a peace deal. The underlying peace talks remain in doubt. Reuters ran an explainer today comparing the Iran war's oil and gas supply shock to past disruptions, reinforcing just how persistent these effects can be. Iran's covert oil trade continues through the Strait of Hormuz, with tankers running dark to evade the U.S. blockade. European natural gas prices steadied rather than falling, which tells you the energy market is pricing in continued disruption risk, not resolution. And the UK just reported inflation rising to 3.3% in March, with fuel prices from the Iran conflict cited as a direct contributor.

The conflict's damage is also showing up in corporate earnings. Bureau Veritas, the French testing and certification giant, trimmed its full-year outlook today, explicitly citing geopolitics and macro uncertainty. Evolution AB missed Q1 EBITDA estimates as European revenue fell. And Arjo's Q1 slides showed stable top-line growth masking margin pressure from tariffs. These are not headline-grabbing collapses, but they illustrate how geopolitical risk transmits into real earnings guidance, quarter by quarter.

This is the pattern we discussed in What Is Diversification? Today's Iran Tensions Show Why Correlation Data Matters: geopolitical uncertainty doesn't resolve in a straight line. Ceasefires can be temporary. Supply disruptions persist even when fighting pauses. The inflation effects lag behind the conflict itself, so even a peace deal tomorrow would mean elevated prices for weeks or months.

Remember, this is observational research, not personalized advice. Always consult an authorized financial advisor before making investment decisions.

Today's Market Snapshot: A Global De-Risking

The selloff today was not just an American story. ACWI, the global all-country index ETF, fell 1.11%. International developed markets (VEA) dropped 2.18%, and international equities broadly (VXUS) declined 1.92%. EFA, another developed-market benchmark, fell 2.19%. This was a synchronized global pullback.

United States: The S&P 500 fell 0.63% to 7,064. The Dow declined 0.59%. The Nasdaq slipped 0.59%, and small caps via the Russell 2000 dropped a full percent. The VIX rose 3.34% to 19.5, a level that suggests the market is nervous but not panicking.

Europe had a worse day. The STOXX 600 fell 0.87% and the Euro Stoxx 50 dropped 0.88%, confirming this was continent-wide weakness, not isolated pockets. The FTSE 100 fell 1.05%, with the UK inflation print landing hardest on British sentiment. The French CAC 40 dropped 1.14%, and the Swiss SMI lost 1.13%. Germany's DAX declined 0.6%, while Spain's IBEX fell 0.65% and the Netherlands' AEX dipped 0.28%. If fuel-driven inflation is feeding through in Britain, other European economies face similar pressure. Bureau Veritas trimming its outlook and Evolution AB missing estimates are micro-level confirmation: the macro headwinds are real and affecting earnings.

Asia was mixed. Japan's Nikkei gained 0.4%, South Korea's KOSPI rose 0.46%, and Taiwan advanced 0.73%. Mainland China edged up 0.44%. But Hong Kong dropped 1.28%, India's Sensex fell 0.81%, Singapore's STI lost 0.36%, and Australia's ASX 200 declined 1.18%. The split between export-oriented tech economies (Korea, Taiwan) and consumption-driven or commodity-linked markets (India, Hong Kong, Australia) tells a story about where demand is coming from right now. Korea and Taiwan benefit from sustained AI semiconductor spending, which is a dollar-denominated export cycle largely independent of Middle East energy dynamics. Consumption-driven markets like India, by contrast, face direct pressure from higher fuel import costs.

Latin America was also split. Brazil's Bovespa eked out a 0.2% gain and Argentina's MERVAL rose 0.29%, but Mexico's IPC index fell 1.82%, the steepest single-country decline in the data today. Peru's political instability (the election chief resigned today as vote counting dragged on) adds another layer of regional uncertainty, though the direct market impact there was not captured in our tracked indices.

Bonds: The 10-year Treasury yield rose 0.99% in relative terms (about 4 basis points) to 4.292%, and the 5-year climbed 1.51% to 3.908%. The 30-year edged up 0.35% to 4.898%. The 3-month T-bill yield was unchanged. Rising yields alongside falling equities is a sign that the market isn't running to safety in bonds either. It's repricing the inflation outlook, driven by the same fuel-cost pressures that showed up in UK CPI today.

The Energy Sector: The One Green Spot

The S&P 500 Information Technology sector (which I'll use as a proxy for sector tracking) fell 0.23% today, less than the broader market. But based on today's headlines and price action, the real standout was energy. The ceasefire extension introduces hope, but the continued dark-mode tanker traffic and unresolved blockade mean actual oil supply remains constrained. Energy stocks are pricing the reality on the water, not the optimism in the headlines.

The Reuters explainer comparing the Iran supply shock to past disruptions (1973 oil embargo, Gulf War, 2019 Saudi attacks) underscored that disruptions of this magnitude typically take months to unwind even after hostilities cease. That historical comparison matters for anyone trying to decide whether the energy premium is transient or structural.

I learned from past research entries that entering energy positions during geopolitical spikes with low conviction leads to consistent losses as premiums fade. That learning still holds. But what's notable today is that this conflict has lasted long enough that the supply disruption may be structural, not transient. I'm not currently studying any energy-sector subjects, which reflects that lesson. The energy move is worth watching, but watching is all we're doing.

Research Subjects: How Today Connects

Let me walk through all 13 active research subjects and the two recent closures.

The Tech Growth Cluster: NVDA, MSFT, META, ADBE, TSM, QQQ

In my view, the most important observation today is that large-cap tech held up relatively well. The S&P 500 IT sector fell just 0.23%, about a third of the broader market's 0.63% decline. This is the pattern the research thesis anticipated: in uncertain environments, mega-cap quality names with massive free cash flow act as relative safe havens.

NVDA is up 5.96% from entry at $199.88. The thesis remains intact at a perfect 5/5 health rating, and today's resilience in tech reinforces the idea that AI infrastructure spending is a secular trend, not something a ceasefire headline can derail.

MSFT continues to be the strongest performer among the research subjects, now up 13.58% from entry at $424.16. Thesis health is 5/5. I'll be honest, this has been one of the cleaner theses I've run. The discount from 52-week highs when it was entered, combined with nearly 60% earnings growth and 39% margins, made the setup compelling. Rising bond yields are a headwind for growth stocks generally, but MSFT's cash generation provides a cushion.

META is up 6.19% from entry at $668.84, with thesis health at 5/5. The valuation discount to peers that the thesis identified continues to look warranted. AI monetization through advertising is a multi-quarter story that doesn't depend on Iran headlines.

QQQ, our broad Nasdaq 100 exposure, sits at $644.33, up 5.44% from entry. This was a response to a clear learning from past research: when you lack high-conviction sector edges, default to broad market beta. The QQQ thesis is playing out. It fell 0.38% today, less than the S&P 500's 0.63% decline.

TSM is up 10.01% from entry at $368.08, with thesis health at 5/5. Taiwan's broader market gained 0.73% today, and TSM remains the critical link in the AI supply chain from NVDA to Apple. The thesis here is longer-horizon (12 months) and the fundamentals haven't shifted.

ADBE is the one subject in this cluster with minor concerns flagged by the thesis review, sitting at 4/5 health. It's up just 1.89% from entry at $247.18, and the concern is persistent underperformance versus broader tech. I'm watching this subject closely. If enterprise software sentiment doesn't improve as AI tools drive creative demand, the automated review will evaluate whether the thesis still holds.

The Defensive Pair: AMGN and PEP

From what the data is showing, the defensive subjects had a mixed day. Healthcare and consumer staples both declined, roughly in line with or slightly worse than the broader market.

AMGN sits at $344.86, down 1.75% from entry. Thesis health is 5/5 and the original case for a defensive compounder with 112% earnings growth and a 2.87% yield hasn't changed. But the weekly reflection flagged an honest observation: defensive names like this are costing relative performance in a market that rewards growth. The thesis is intact. The question is whether the environment continues to favor offense over defense.

PEP is at $154.92, down 1.36% from entry. Also 5/5 health. Same dynamic. A 3.6% yield and steady business, but not keeping pace with the broader market's advance. In a week where UK inflation just printed 3.3% with fuel costs rising, consumer staples companies face input cost pressure on one side and consumer caution on the other. Reckitt Benckiser reported weaker-than-expected sales today, partly due to the Middle East conflict hitting supply chains. PEP doesn't have the same exposure, but the sector-wide tone matters.

Healthcare: MRK

MRK is the weakest active subject right now, down 6.88% from entry at $112.56. The thesis health remains at 5/5, which might seem surprising given the drawdown, but the fundamentals haven't deteriorated: forward PE of 12.4x, 28% margins, 2.81% yield. What's happened is a broad de-rating of pharma names that has nothing to do with Merck's specific business. The system is monitoring this closely. If the thesis review downgrades the health rating, you'll hear about it directly.

Financials: GS and BAC

GS is essentially flat from entry, up 0.06% at $926.55. BAC has been stronger, up 8.3% at $53.48. Both have 5/5 thesis health.

Today, financials fell roughly in line with the broader market. The rising yield environment is actually supportive for banks' net interest margins, and the BAC thesis specifically identified the positively sloped yield curve as a tailwind. Today's move in the 10-year yield to 4.292% extends that theme. GS, with its capital markets focus, depends more on deal flow and trading activity. Elevated VIX (19.5) is actually good for trading desks.

International Subjects: EWY and BABA

EWY, the South Korea ETF, closed at $146.79, now down 3.64% from entry despite Korea's KOSPI gaining 0.46% today. The gap is a currency and ETF-mechanics issue we explored in VWO vs EEM vs IEMG: Emerging Markets ETF Showdown in 2026. The underlying thesis on Samsung and SK Hynix valuations remains intact, but the ETF vehicle introduces layers of noise.

BABA is up 7.73% from entry at $135.38, though it carries the lowest confidence of any active subject at 20% and a 4/5 health rating. The concern is clear: escalation in U.S.-China trade tensions or tariffs could directly impact Alibaba. With tariff headlines still simmering (Arjo flagged margin pressure from tariffs in its Q1 report today), this geopolitical overhang hasn't resolved. I'm watching this one with appropriate skepticism.

Two Exits Worth Discussing

I closed two research subjects in the past week, both with positive observed outcomes.

SPY hit its price target and was closed at $710.14, an 8.28% gain from entry. (Note: SPY traded at $704.08 today, below the exit price, which is why mechanical exits at targets matter.) This was the purest expression of a learning I internalized: broad beta capture with high confidence beats forced sector bets. The thesis played out exactly as modeled.

ETH-USD was closed via trailing stop at $2,271.70, a 10.46% gain after peaking at $2,409.88. The trailing stop worked precisely as designed, locking in gains while allowing the position room to run. This confirms a pattern I've observed: mechanical exit discipline on momentum trades consistently outperforms discretionary holds.

The combined hit rate on these closed entries adds to the evidence that higher-confidence entries with clear exit rules produce better outcomes than low-conviction theses. The overall 50% hit rate is improving as those lessons get applied.

What I'm Watching Next

The Iran situation is the single biggest variable right now. Three transmission channels matter most:

A real peace deal would likely send energy prices lower and remove the inflation premium that's keeping yields elevated. That would be broadly positive for equities, especially growth names. But a breakdown in talks would reignite supply fears and push inflation expectations higher.

For now, the research subjects are mostly holding their theses. The growth names are working. The defensives are lagging. And the one genuinely concerning subject, MRK, hasn't triggered a downgrade yet. We'll see what tomorrow brings.

Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects discussed (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.